Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19. Vaduganathan, M., Vardeny, O., Michel, T., McMurray, J. J., Pfeffer, M. A., & Solomon, S. D. New England Journal of Medicine, March, 2020. Publisher: Massachusetts Medical Society
Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19 [link]Paper  doi  bibtex   
@article{vaduganathan_reninangiotensinaldosterone_2020,
	title = {Renin–{Angiotensin}–{Aldosterone} {System} {Inhibitors} in {Patients} with {Covid}-19},
	issn = {0028-4793},
	url = {https://doi.org/10.1056/NEJMsr2005760},
	doi = {10.1056/NEJMsr2005760},
	urldate = {2020-04-05},
	journal = {New England Journal of Medicine},
	author = {Vaduganathan, Muthiah and Vardeny, Orly and Michel, Thomas and McMurray, John J.V. and Pfeffer, Marc A. and Solomon, Scott D.},
	month = mar,
	year = {2020},
	note = {Publisher: Massachusetts Medical Society},
	keywords = {ACE2, RAAS inhibitors, inhibitors, renin-angiotensis-aldosterone system}
}

Downloads: 0